Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Pliant Therapeutics (PLRX) Long-Term Debt Issuances (2022 - 2024)

Pliant Therapeutics has reported Long-Term Debt Issuances over the past 2 years, most recently at $1000.0 for Q4 2024.

Quarterly Long-Term Debt Issuances changed N/A to $1000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Sep 2025, down 99.99% year-over-year, with the annual reading at $19.9 million for FY2024, N/A changed from the prior year.
Long-Term Debt Issuances was $1000.0 for Q4 2024 at Pliant Therapeutics, down from $19.9 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $19.9 million in Q1 2024 and troughed at -$150000.0 in Q4 2022.